Spruce Biosciences | 4:持股变动声明-董事 SPIEGELMAN DANIEL K
Spruce Biosciences | 4:持股变动声明-董事 Ways Kirk
Spruce Biosciences | 4:持股变动声明-董事 SIMPSON CAMILLA V
Spruce Biosciences | 4:持股变动声明-董事 Barretto-Ko Percival
Spruce Biosciences | 4:持股变动声明-高管 GREY MICHAEL G
Spruce Biosciences | 4:持股变动声明-董事 Muralidhar Bali
Spruce Biosciences | 4:持股变动声明-董事 Aynechi Tiba
Spruce Biosciences | 8-K:重大事件
Spruce Biosciences | 10-Q:季度报表
Spruce Biosciences | 8-K:Spruce Biosciences公布2024年第一季度财务业绩并提供公司最新情况
Spruce Biosciences | 8-K:重大事件
Spruce Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Rosalind Advisors, Inc.(3.67%),Steven Salamon(3.67%)等
Spruce Biosciences | ARS:年度报告
Spruce Biosciences | DEFA14A:其他
Spruce Biosciences | DEF 14A:股东委托书决议
Spruce Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Novo Holdings A/S(3.9%)
Spruce Biosciences | SC 13G:超过5%持股股东披露文件-Bradley L. Radoff(6.9%)
Spruce Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Novo Holdings A/S(6.4%)
Spruce Biosciences | 4:持股变动声明-股东 Novo Holdings A/S
Spruce Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Novo Holdings A/S(10.9%)
暂无数据